BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34390698)

  • 1. Birth Characteristics Among Children Diagnosed with Neurofibromatosis Type 1 and Tuberous Sclerosis.
    Tettamanti G; Mogensen H; Kampitsi CE; Nordgren A; Feychting M
    J Pediatr; 2021 Dec; 239():200-205.e2. PubMed ID: 34390698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden.
    Kampitsi CE; Nordgren A; Mogensen H; Pontén E; Feychting M; Tettamanti G
    JAMA Netw Open; 2023 Jul; 6(7):e2325482. PubMed ID: 37490289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 of the child increases birth weight.
    Leppävirta J; Kallionpää RA; Uusitalo E; Vahlberg T; Pöyhönen M; Peltonen J; Peltonen S
    Am J Med Genet A; 2019 Jul; 179(7):1173-1183. PubMed ID: 31016862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
    Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
    Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hallazgos clínicos y epidemiológicos en la neurofibromatosis tipo 1 y el complejo esclerosis tuberosa en una serie de pacientes pediátricos].
    Cammarata-Scalisi F; Stock F; Velazco N; Silva GD; Lacruz-Rengel MA; Avendaño A
    Bol Med Hosp Infant Mex; 2018; 75(5):287-294. PubMed ID: 30250319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.
    Kandt RS
    Neurol Clin; 2003 Nov; 21(4):983-1004. PubMed ID: 14743661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new with common genetic skin disorders?
    Hand JL
    Curr Opin Pediatr; 2015 Aug; 27(4):460-5. PubMed ID: 26164153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.
    Kandt RS
    Neurol Clin; 2002 Nov; 20(4):941-64. PubMed ID: 12616676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallels between tuberous sclerosis complex and neurofibromatosis 1: common threads in the same tapestry.
    Gutmann DH
    Semin Pediatr Neurol; 1998 Dec; 5(4):276-86. PubMed ID: 9874855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phakomatoses.
    Becker B; Strowd RE
    Dermatol Clin; 2019 Oct; 37(4):583-606. PubMed ID: 31466597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocutaneous syndromes: neurofibromatosis 1, neurofibromatosis 2, and tuberous sclerosis.
    Korf BR
    Curr Opin Neurol; 1997 Apr; 10(2):131-6. PubMed ID: 9146993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic thiol/disulphide homeostasis in children with neurofibromatosis type 1 and tuberous sclerosis.
    Incecik F; Avcıoğlu G; Erel Ö; Neşelioğlu S; Besen S; Altunbaşak S
    Acta Neurol Belg; 2019 Sep; 119(3):419-422. PubMed ID: 30820867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous sclerosis associated with neurofibromatosis: report of a case.
    Lee TC; Sung ML; Chen JS
    J Formos Med Assoc; 1994 Sep; 93(9):797-801. PubMed ID: 7735010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MRT in neurofibromatosis and tuberous sclerosis].
    Higer HP; Just M; Vahldiek G; Gutjahr P; Pfannenstiel P
    Rofo; 1987 Jul; 147(1):64-8. PubMed ID: 3039604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double phakomatosis; neurofibromatosis type-1 and tuberous sclerosis.
    Alaraj AM; Valyi-Nagy T; Roitberg B
    Acta Neurochir (Wien); 2007; 149(5):505-9; discussion 509. PubMed ID: 17406778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocutaneous syndromes.
    Rose VM
    Mo Med; 2004; 101(2):112-6. PubMed ID: 15119108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigmentary disorders: update on neurofibromatosis-1 and tuberous sclerosis.
    Arbuckle HA; Morelli JG
    Curr Opin Pediatr; 2000 Aug; 12(4):354-8. PubMed ID: 10943816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex.
    Shapira Rootman M; Goldberg Y; Cohen R; Kropach N; Keidar I; Friedland R; Dotan G; Konen O; Toledano H
    Clin Genet; 2020 Feb; 97(2):296-304. PubMed ID: 31730237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-ophthalmic features of the neurocutaneous syndromes.
    Chan JW
    Int Ophthalmol Clin; 2012; 52(3):73-85, xi. PubMed ID: 22668541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.